HERA Biotech is developing and commercializing a non-surgical diagnostic test for definitive diagnosis and staging of endometriosis.

HERA Biotech

Our Vision: To be the world leader in understanding & addressing diagnostic & therapeutic deficiencies in women's health. 
Our Mission: Driven to advance the standard of care in women's health 
Our First Order of Business: Validate and commercialize the first non-surgical method of diagnosing, and staging, endometriosis.

Althea Ventures

Kendra Scott Women's Entrepreneurial Leadership Institute

Stella Angels

Coyote Ventures

Hera Biotech

Hey, hey, hey!!! So proud that our company was selected from >1000 applicants as one of the 10 to participate in this, Class 10! Here we goooo!

So proud to see our CEO Somer Baburek, MBA, and our team at Hera being recognized for our work in #womenshealth!

At Hera, we are incredibly passionate about improving definitive diagnostics for endometriosis, taking it from surgical to simple, but always recognizing the importance of a tissue-based connection with a tissue-based disease. We also see the importance of elucidating the whole burden of endometriosis. It's easy to minimize the impact of something that is not directly affecting you or a loved one. We believe that endometriosis harms the whole of society, not just those that it immediately impacts, and we have dedicated precious resources to the research needed to prove this. 

We are so very pleased to present our 4th white paper in this series. We cannot thank Mark Gannott, A/Prof Mike Armour, Ryan Castle, Diana Nancy Contreras, MD MPH, Ally Schott, and Emma Ricci-De Lucca, the team that worked to get this paper done. This one was a heavy lift and they delivered something so data-driven, yet so easy to digest. Thank you to each of you, we are so appreciative of your dedication.

Please view the visual executive summary below and read the new Hera white paper here: https://lnkd.in/gwt8RzuC

#endometriosis #womenshealth #biotech #surgicaltosimple #socialdeterminantsofhealth

Experience, expertise, and innovation: Hera's team brings a wealth of knowledge in medical diagnostics development, approval, and more. MetriDx™, the groundbreaking diagnostic test for endometriosis, will expand access for OB/GYNs and fertility clinics. At Hera Biotech, our commitment lies in enhancing our understanding of endometriosis and creating an accessible diagnostic test for women grappling with this condition.

#FromSurgicalToSimple

Talking about endometriosis can be as tricky as explaining a color you've never seen. It's intimate, it's personal, and it's often met with misunderstanding. We know it can be difficult, but it doesn't have to be! Here are a few ways you can openly explain endometriosis to someone.
#FromSurgicalToSimple

Did you know there are incredible support groups like Endometriosis Association, EndoFound, SpeakEndo, and many more? Connect with others who understand your journey, share experiences, and access invaluable resources. You're not alone. 💛
#EndometriosisSupport #FromSurgicalToSimple

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

logo

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	Aug 31, 2024 10:57 AM	bc066bf1
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
peers	general	Aug 31, 2024 10:57 AM	ec58c742
news basic	general	Aug 31, 2024 10:57 AM	e768eab7
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
logo	meta
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:HERABIOTECH

HERA Biotech